AMLX
Price
$3.35
Change
-$0.15 (-4.27%)
Updated
Apr 4, 02:28 PM (EDT)
Capitalization
310.99M
34 days until earnings call
RGNX
Price
$6.33
Change
-$0.34 (-5.10%)
Updated
Apr 4, 04:20 PM (EDT)
Capitalization
334.07M
26 days until earnings call
Ad is loading...

AMLX vs RGNX

Header iconAMLX vs RGNX Comparison
Open Charts AMLX vs RGNXBanner chart's image
Amylyx Pharmaceuticals
Price$3.35
Change-$0.15 (-4.27%)
Volume$400
Capitalization310.99M
REGENXBIO
Price$6.33
Change-$0.34 (-5.10%)
Volume$700
Capitalization334.07M
AMLX vs RGNX Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. RGNX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and RGNX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMLX: $3.51 vs. RGNX: $6.67)
Brand notoriety: AMLX and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 91% vs. RGNX: 94%
Market capitalization -- AMLX: $310.99M vs. RGNX: $334.07M
AMLX [@Biotechnology] is valued at $310.99M. RGNX’s [@Biotechnology] market capitalization is $334.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • RGNX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than RGNX.

Price Growth

AMLX (@Biotechnology) experienced а -9.30% price change this week, while RGNX (@Biotechnology) price change was -15.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

AMLX is expected to report earnings on May 08, 2025.

RGNX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($334M) has a higher market cap than AMLX($311M). AMLX YTD gains are higher at: -7.143 vs. RGNX (-13.713). RGNX has higher annual earnings (EBITDA): -198.23M vs. AMLX (-290.98M). RGNX has more cash in the bank: 235M vs. AMLX (177M). AMLX has less debt than RGNX: AMLX (1.98M) vs RGNX (82M). AMLX (87.4M) and RGNX (83.3M) have equivalent revenues.
AMLXRGNXAMLX / RGNX
Capitalization311M334M93%
EBITDA-290.98M-198.23M147%
Gain YTD-7.143-13.71352%
P/E Ratio2.69N/A-
Revenue87.4M83.3M105%
Total Cash177M235M75%
Total Debt1.98M82M2%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXRGNX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADGIX24.29N/A
N/A
AB Core Opportunities I
SLVCX16.42N/A
N/A
Saratoga Large Capitalization Value C
PRRAX29.09N/A
N/A
Principal Real Estate Securities A
RTSAX36.37N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap A
SSBIX12.68N/A
N/A
State Street Balanced Index K

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-7.14%
XOMAO - AMLX
68%
Closely correlated
+1.46%
IKNA - AMLX
54%
Loosely correlated
-4.00%
XOMAP - AMLX
51%
Loosely correlated
+0.90%
JAZZ - AMLX
43%
Loosely correlated
-4.44%
RGNX - AMLX
43%
Loosely correlated
-5.39%
More